Less therapist time, same recovery? a new stroke rehab approach puts Self-Supervised therapy to the test

NCT ID NCT07723300

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests a partially self-supervised version of constraint-induced movement therapy (sCIMT) for adults with arm and hand weakness after a stroke. Over two weeks, participants complete up to 30 hours of therapy, with about one-third guided by a therapist and two-thirds done independently. The study aims to see whether this approach improves arm function, feels acceptable and useful to participants, and boosts quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a self-supervised constraint-induced movement therapy (sCIMT) program combining therapist-guided and independent task practice
What this could lead to
If it works, this could point toward a more accessible, less therapist-intensive way to help stroke survivors regain arm and hand function.
What could go wrong
This is a very small, early feasibility study with only 12 participants. The results may not apply to all stroke survivors, and the self-supervised approach may not be as effective as full therapist-led therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL VASCULAR ACCIDENT (CVA)/STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.